US 12,226,447 B2
Composition comprising an algal proteoglycan extract and use thereof
Qing Qi, Beijing (CN); and Jian Ding, Shanghai (CN)
Filed by Qing Qi, Beijing (CN); and Jian Ding, Shanghai (CN)
Filed on Apr. 6, 2023, as Appl. No. 18/296,774.
Application 16/922,585 is a division of application No. 16/071,020, granted, now 10,729,743, issued on Aug. 4, 2020, previously published as PCT/CN2017/071861, filed on Jan. 20, 2017.
Application 18/296,774 is a continuation of application No. 16/922,585, filed on Jul. 7, 2020, granted, now 11,648,288.
Claims priority of application No. 201610037244.6 (CN), filed on Jan. 20, 2016.
Prior Publication US 2023/0241160 A1, Aug. 3, 2023
Int. Cl. A61K 38/16 (2006.01); A61K 9/00 (2006.01); A61K 31/282 (2006.01); A61K 31/513 (2006.01); A61K 31/675 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 35/748 (2015.01); A61K 36/02 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01)
CPC A61K 38/164 (2013.01) [A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61K 31/282 (2013.01); A61K 31/513 (2013.01); A61K 31/675 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 35/748 (2013.01); A61K 36/02 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01)] 9 Claims
OG exemplary drawing
 
1. A method for treating an esophageal cancer that is a squamous cell carcinoma (SCC) in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of an algal proteoglycan extract or a therapeutic composition comprising a therapeutically effective amount of the algal proteoglycan extract.